118 related articles for article (PubMed ID: 38382303)
1. NQO1-activated multifunctional theranostic probe for imaging-guided mitochondria-targeted photodynamic therapy and boosting immunogenic cell death.
Cao C; Li J; Zhang X; Zhang X; Gong X; Wang S
Talanta; 2024 May; 272():125786. PubMed ID: 38382303
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic NQO1 Enzyme-Activated Near-Infrared Fluorescence Imaging and Photodynamic Therapy with Polymeric Vesicles.
Yao C; Li Y; Wang Z; Song C; Hu X; Liu S
ACS Nano; 2020 Feb; 14(2):1919-1935. PubMed ID: 31935063
[TBL] [Abstract][Full Text] [Related]
3. An Activatable Near-Infrared Afterglow Theranostic Prodrug with Self-Sustainable Magnification Effect of Immunogenic Cell Death.
Gao Z; Jia S; Ou H; Hong Y; Shan K; Kong X; Wang Z; Feng G; Ding D
Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202209793. PubMed ID: 35916871
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
[TBL] [Abstract][Full Text] [Related]
5. A mitochondria-targeted molecular phototheranostic platform for NIR-II imaging-guided synergistic photothermal/photodynamic/immune therapy.
Yang S; Wu GL; Li N; Wang M; Wu P; He Y; Zhou W; Xiao H; Tan X; Tang L; Yang Q
J Nanobiotechnology; 2022 Nov; 20(1):475. PubMed ID: 36369039
[TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
[TBL] [Abstract][Full Text] [Related]
7. Advances in Multifunctional Chemotherapeutic Prodrugs for Near-infrared Fluorescence Imaging-guided Therapy.
Zeng J; Liu M; Li S; Cheng D; He L; Yuan L
Chembiochem; 2023 Jun; 24(12):e202300035. PubMed ID: 36802094
[TBL] [Abstract][Full Text] [Related]
8.
Zou R; Gao Y; Zhang Y; Jiao J; Wong KL; Wang J
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9667-9680. PubMed ID: 33617721
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging-guided photothermal/photodynamic therapy against tumor by iRGD-modified indocyanine green nanoparticles.
Yan F; Wu H; Liu H; Deng Z; Liu H; Duan W; Liu X; Zheng H
J Control Release; 2016 Feb; 224():217-228. PubMed ID: 26739551
[TBL] [Abstract][Full Text] [Related]
10. High-contrast NIR fluorescent probes for selective detection of NQO1 in breast cancer.
Liu H; Hu F; Cao Z; Qu Y; Wen H; Wang X; Li W
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 311():123898. PubMed ID: 38340443
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Nanoplatform: Enabling a Precise Antitumor Strategy via Dual-Modal Imaging-Guided Photodynamic/Chemo-/Immunosynergistic Therapy.
Chen H; Wu F; Xie X; Wang W; Li Q; Tu L; Li B; Kong X; Chang Y
ACS Nano; 2021 Dec; 15(12):20643-20655. PubMed ID: 34878760
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of NQO1 responsive fluorescence probe and its application in bio-imaging for cancer diagnosis.
Yuan Z; Xu M; Wu T; Zhang X; Shen Y; Ernest U; Gui L; Wang F; He Q; Chen H
Talanta; 2019 Jun; 198():323-329. PubMed ID: 30876568
[TBL] [Abstract][Full Text] [Related]
13. Self-Luminescing Theranostic Nanoreactors with Intraparticle Relayed Energy Transfer for Tumor Microenvironment Activated Imaging and Photodynamic Therapy.
Wu M; Wu L; Li J; Zhang D; Lan S; Zhang X; Lin X; Liu G; Liu X; Liu J
Theranostics; 2019; 9(1):20-33. PubMed ID: 30662551
[TBL] [Abstract][Full Text] [Related]
14. Dual-Mode Imaging Guided Multifunctional Theranosomes with Mitochondria Targeting for Photothermally Controlled and Enhanced Photodynamic Therapy in Vitro and in Vivo.
Wang S; Guo F; Ji Y; Yu M; Wang J; Li N
Mol Pharm; 2018 Aug; 15(8):3318-3331. PubMed ID: 29975536
[TBL] [Abstract][Full Text] [Related]
15. Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics as a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy.
Yang H; He Y; Wang Y; Yang R; Wang N; Zhang LM; Gao M; Jiang X
Int J Nanomedicine; 2020; 15():3023-3038. PubMed ID: 32431499
[TBL] [Abstract][Full Text] [Related]
16. An Activatable Theranostic Nanoprobe for Dual-Modal Imaging-Guided Photodynamic Therapy with Self-Reporting of Sensitizer Activation and Therapeutic Effect.
Zhang Z; Wang R; Luo R; Zhu J; Huang X; Liu W; Liu F; Feng F; Qu W
ACS Nano; 2021 Mar; 15(3):5366-5383. PubMed ID: 33705106
[TBL] [Abstract][Full Text] [Related]
17. Theranostic polymeric nanoparticles for NIR imaging and photodynamic therapy.
Sarcan ET; Silindir-Gunay M; Ozer AY
Int J Pharm; 2018 Nov; 551(1-2):329-338. PubMed ID: 30244148
[TBL] [Abstract][Full Text] [Related]
18. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy.
Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y
Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647
[TBL] [Abstract][Full Text] [Related]
19. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
20. Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy.
Shin WS; Han J; Verwilst P; Kumar R; Kim JH; Kim JS
Bioconjug Chem; 2016 May; 27(5):1419-26. PubMed ID: 27135737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
